COMPASS Pathways plc (FRA:5Y6)
Germany · Delayed Price · Currency is EUR 12.40
+0.40 (3.33%)
At close: Aug 26, 2026
COMPASS Pathways Market Cap
COMPASS Pathways has a market cap or net worth of €1.74 billion as of August 26, 2026. Its market cap has increased by 360.43% in one year.
Market Cap
1.74B
Enterprise Value
1.41B
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
€12.40
ChartMarket Cap Chart
Since September 18, 2020, COMPASS Pathways's market cap has increased from 449.43M to 1.74B, an increase of 286.37%. That is a compound annual growth rate of 25.57%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 25, 2026 | 1.77B | 212.91% |
| Dec 31, 2025 | 564.27M | 125.88% |
| Dec 31, 2024 | 249.81M | -49.02% |
| Dec 29, 2023 | 489.98M | 53.16% |
| Dec 30, 2022 | 319.91M | -60.55% |
| Dec 31, 2021 | 810.94M | -42.05% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Sep 18, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Biotest GmbH & Co. KGaA | 1.32B |
| Novogenia AG | 69.60M |
| 2invest AG | 43.64M |
| Biomark Diagnostics | 30.45M |
| Vidac Pharma Holding | 23.64M |
| co.don AG | 360.77K |
| Paion AG | 328.15K |
| bioXXmed AG | 225.65K |